JP6431122B2 - Intravascular aortic repair device and method of use thereof - Google Patents

Description

[Cross-reference of related applications]
This application is filed on Dec. 6, 2011 by Ali Shahriari, entitled “Transcathetar Aortic Valve for Endovascular Aortic Repair”, US Provisional Patent Application No. 61 / 567,458 as defined in Section 119 of the US Patent Act. Claim priority, the contents of which are expressly incorporated herein by reference. This application is also filed by US Provisional Patent Application No. 61/723, filed November 7, 2012, entitled “Transcathetar Aortic Valve for Endovascular Aortic Repair,” filed in US Patent Act No. 119, filed by Ali Shahriari. 446 claims priority, the contents of which are expressly incorporated herein by reference.

  The present invention relates to blood vessels including repair of aortic valve disease, aortic stenosis, ascending aortic aneurysm, aortic regurgitation, aortic regurgitation, ascending aneurysm, bicuspid valve disease, and / or type A dissection The present invention relates to a device for repairing an internal aorta and a method for using the same.

  The normal aortic root and ascending aorta are composed of the aortic annulus, Valsalva sinus, ST junction (sinutubular junction) and tubular part. Problems faced by specialists in endovascular repair of ascending aortic aneurysms include: That is, there is a very short proximal landing zone at the ST junction location, each patient has a different coronary structure, and aortic valve lesions often associated with either valve regurgitation or stenosis There is. As described in Non-Patent Document 1, there are generally three basic types of lesions in the ascending aorta, which are referred to as A type, B type, and C type, respectively. These will be described in detail below with reference to FIGS. 1A to 1C copied from the prior art documents. The disclosure of Non-Patent Document 1 is fully incorporated herein by reference.

  Type A aneurysms are most commonly seen in young patients and patients with connective tissue disorders such as Marfan syndrome. An anatomical feature of type A aneurysms is the enlargement of the Valsalva sinus, which may or may not be accompanied by an enlargement of the aortic annulus. ST junctions expand most frequently. The valve condition can be a normal valve, a stenosis valve, or a valve regurgitation. An example of an A-type aneurysm is shown in FIG. 1A.

  An anatomical feature of a B-type aneurysm is an enlargement of the tubular portion. Initially, the ST junction is normal or slightly enlarged, but as the aneurysm grows, the ST junction is stretched, eventually causing aortic regurgitation. The condition of the valve can be a normal valve, a stenosis valve, or a valve insufficiency. Most of the aneurysms are at the tubular aorta. An example of a B-type aneurysm is shown in FIG. 1B.

  The anatomical features of a C-type aneurysm are the enlargement of the aortic Valsalva sinus, ST junction, and tubular section. The condition of the valve can be a normal valve, a stenosis valve, or a valve insufficiency. B-type aneurysms and C-type aneurysms are most commonly seen in older patient groups. An example of a C-type aneurysm is shown in FIG. 1C.

  There are devices that are used clinically for endovascular repair of ascending aortic aneurysms. Although transcatheter valves have been realized in clinical treatment, none of those in clinical use has yet been designed for use in endovascular repair of multiple types of ascending aortic aneurysms. While allowing the treatment of various anatomical variations of the ascending aortic aneurysm and the creation of effective proximal and distal seal regions within the aorta, while allowing for future valve re-treatment There is a real need for devices having durable valve components. It also allows for the treatment of various coronary anatomical variations that vary between patient populations and allows for future re-treatment of coronary arteries while preventing compression of coronary arteries and treatment of possible paravalvular leaks There is also a need for a device that allows for this.

US Pat. No. 5,102,417 US Pat. No. 6,582,462

James E. Davies, Thralf M. Sundt, “Surgery Insight: SURGERY INSIGHT: THE DILATED ASCENDING AORTA-INDICATIONS FOR SURGICAL INTERVENTION”, Nature Clinical Practice Cardiovascular Medicine (2007)

  According to one aspect of the present disclosure, an endograft device for endovascular repair of an ascending aortic aneurysm is disclosed. The endograft device includes a first prosthesis component, the first prosthesis component being secured to the proximal frame and a distal end extending to the distal end of the first prosthesis component. A position frame. An end graft device is also secured to the first prosthesis component, at least one conduit located adjacent to the proximal frame, and a second secured to the proximal end of the first prosthesis component. Prosthetic parts are provided. The second prosthesis component includes a balloon expandable frame extending distally from a proximal end of the second prosthesis component, and a second end of the second prosthesis component connected to the balloon expandable frame. A self-expanding frame extending up to. The end graft device further comprises a valve element secured to the balloon expandable frame at a proximal end of the second prosthetic component.

  In some embodiments, the self-expanding frame can be hourglass shaped. In some embodiments, the self-expanding frame may include a first portion that tapers inwardly between a proximal end and a distal end. The end graft device may further comprise a second portion having a proximal end secured to the distal end of the first portion. The second portion may taper outwardly between the proximal and distal ends of the second portion. Further, in some embodiments, the proximal end of the first portion may be coupled to the distal end of the balloon expandable frame.

  In some embodiments, the self-expanding frame may comprise a third portion that extends proximally from the proximal end of the first portion. The third portion may have a passage defined therein, and the balloon expandable frame may be disposed within the passage of the third portion of the self-expanding frame. In some embodiments, the balloon expandable frame includes an unexpanded position, wherein the outer surface of the balloon expandable frame is spaced from the inner surface of the self-expandable frame, and the outer surface of the balloon expandable frame is It can be expandable between an expanded position that engages the inner surface of the self-expanding frame.

  In some embodiments, a plurality of fibers may be attached to the third portion of the self-expanding frame. When the balloon expandable frame is in the expanded position, the outer surface of the balloon expandable frame can engage a plurality of fibers.

  In some embodiments, the proximal frame of the first prosthesis component has a passage defined therein and the distal end of the second prosthesis component is located within the passage of the first prosthesis component. You may let them.

  In some embodiments, the conduits may be a pair of conduits located on opposite sides of the first prosthesis component. In some embodiments, the conduit may also have a proximal opening located adjacent to the proximal end of the first prosthesis component.

  In some embodiments, the proximal frame may comprise a first portion secured to the distal end of the second prosthesis component and a second portion coupled to the first portion. The second portion may taper outwardly between the distal end and the proximal end that connects to the first portion. The conduit may have a distal opening defined in the second portion of the proximal frame.

  In some embodiments, the endograft device also includes a stent having a distal end located within the proximal opening of the at least one conduit and a proximal end configured to be located within the coronary artery. May be.

  In some embodiments, the outer surface of the second prosthesis component and the outer surface of the proximal frame of the first prosthesis component may be coated to prevent fluid permeation to each surface. Further, the outer surface of the distal frame of the first prosthetic component may be covered without allowing the fluid to permeate the surface.

  According to another aspect, a transcatheter valve is disclosed. The transcatheter valve includes a frame component, the frame portion including a balloon expandable frame extending distally from a proximal end of the frame component and a self-expandable frame secured to the balloon expandable frame. Is provided. The self-expanding frame is between a first portion that tapers inwardly between a proximal end and a distal end, a distal end, and a proximal end secured to the distal end of the first portion. A second portion that tapers outwardly. A valve element is located within the balloon expandable frame at the proximal end of the frame part.

  In some embodiments, the frame part may be a double frame part. The self-expanding frame is an outer frame of a double frame part and may have a passage defined therein. A balloon expandable frame is an inner frame of the double frame part and may be located in a passage defined in the self-expanding frame. The balloon-expandable frame has an unexpanded position where an outer surface of the balloon-expandable frame is separated from an inner surface of the self-expandable frame, and an outer surface of the balloon-expandable frame is the self-expandable frame. It may be expandable between expanded positions that engage the inner surface of the.

  In some embodiments, a plurality of fibers may be attached to the self-expanding frame. When the balloon expandable frame is in the expanded position, the outer surface of the balloon expandable frame can engage the plurality of fibers. Also, in some embodiments, the outer surface of the first portion of the self-expanding frame may be covered without allowing the fluid to permeate the surface, and the outer portion of the second portion of the self-expanding frame may be allowed to penetrate. A surface may be coated to prevent permeation of fluid to the surface.

  In some embodiments, the self-expanding frame may include an elongated portion that extends distally from the second portion. The length of the long part may be longer than the combined length of the first part and the second part. In some embodiments, the self-expanding frame may be coated with at least one of collagen and hydrogel. In some embodiments, the valve element may be a bicuspid or tricuspid valve.

  According to another aspect, a method for repairing a patient's aorta is disclosed. The method introduces a first prosthetic component into the patient's aorta to position a proximal frame of the first prosthetic component in the ascending aorta and a distal frame of the first prosthetic component to the patient. Introducing into a coronary artery of the patient's aorta through a conduit defined in the first prosthetic component; introducing the stent to be positioned within the aortic arch of the aorta of the patient; and second prosthesis Securing the component within the patient's aorta with the proximal end of the first prosthetic component; and expanding the proximal portion of the second prosthetic component to the aortic annulus of the patient's aorta Engaging and expanding a valve element secured to the proximal portion into aortic annulus proximal to the coronary artery.

  In some embodiments, expanding the proximal portion of the second prosthesis component may include operating a balloon expandable frame. Also, in some embodiments, expanding the proximal portion of the second prosthetic component may include expanding a self-expanding frame to engage the aortic annulus, Operating the frame includes extending the outer surface of the balloon expandable frame to engage the inner surface of the self-expandable frame after the self-expandable frame is engaged with the aortic annulus. And a step of performing.

  In some embodiments, operating the balloon expandable frame may include extending the outer surface of the balloon expandable frame to engage the aortic annulus.

  In some embodiments, the outer surface of the second prosthesis component and the outer surface of the proximal frame of the first prosthesis component may be coated to prevent fluid permeation to the surface. Further, the outer surface of the distal frame of the first prosthetic component may be covered without allowing the fluid to permeate the surface.

  In some embodiments, introducing the first prosthetic component into a patient's aorta and advancing a covered stent through the conduit defined in the first prosthetic component into the coronary artery of the patient's aorta. May be performed in the first surgical procedure. In some embodiments, a second prosthetic component is secured to a proximal end of the first prosthetic component, and a proximal portion of the second prosthetic component is expanded to provide a patient aorta. The step of engaging with the aortic valve annulus may be performed in a second surgical procedure different from the first surgical procedure.

  In some embodiments, a method of repairing a patient's aorta may also include introducing a second prosthetic component into the ascending aorta and then introducing the first prosthetic component.

It is a figure which shows the example of an aorta. FIG. 1A is a diagram illustrating an example of an aorta, and FIG. 1A is a diagram illustrating an example of an A-type aneurysm. It is a figure which shows the example of an aorta, and FIG. 1B is a figure which shows an example of a B type aneurysm. FIG. 1C is a diagram illustrating an example of an aorta, and FIG. 1C is a diagram illustrating an example of a C-type aneurysm. 1 is a partial cutaway view of an aorta implanted with an embodiment of an endovascular prosthesis device. FIG. FIG. 3 is a front view of a proximal prosthesis component in the endovascular prosthesis device shown in FIG. 2. FIG. 3 is a front view of a distal prosthesis component in the endovascular prosthesis device shown in FIG. 2. FIG. 5 is a cross-sectional view of the distal prosthesis component shown in FIG. 4, showing a cross-section along line 5-5 of FIG. 4. FIG. 4 is a partial cutaway view of the aorta implanted with the distal prosthesis component shown in FIG. 3. FIG. 7 is a view similar to FIG. 6 showing a stent extending from a distal prosthesis component. FIG. 6 is a front view showing another embodiment of a proximal prosthesis component in the endovascular prosthesis device shown in FIG. 2. FIG. 9 is a front view of a self-expanding outer frame in the proximal prosthesis component shown in FIG. 8. FIG. 9 is a front view of a balloon expandable inner frame in the proximal prosthesis component shown in FIG. 8. FIG. 9 is a perspective view of the proximal end of the proximal prosthesis component shown in FIG. 8. FIG. 13 is a front cross-sectional view of the proximal prosthesis component shown in FIG. 8 and shows a cross-section taken along line 12-12 of FIG. FIG. 9 is a plan view of the proximal prosthesis component shown in FIG. 8, showing the inner frame in an unexpanded position. It is a top view similar to FIG. 13, and is a figure which shows the internal frame in an extended position. FIG. 9 is a partial cutaway view of the aorta showing both the distal prosthesis component shown in FIG. 4 secured to the proximal prosthesis component shown in FIG. FIG. 16 is a view similar to FIG. 15 and showing the internal frame in the extended position. FIG. 4 illustrates an embodiment of a transcatheter valve device similar to the proximal prosthesis component shown in FIG. 3. FIG. 18 is a partial cutaway view of an aorta having a transcatheter valve shown in FIG. 17 implanted therein. FIG. 18 is a partial cutaway view of an aorta having a transcatheter valve shown in FIG. 17 implanted therein. FIG. 9 illustrates another embodiment of a transcatheter valve device similar to the proximal prosthesis component shown in FIG. FIG. 21 is a partial cutaway view of the aorta having the transcatheter valve shown in FIG. 20 implanted therein. FIG. 21 is a partial cutaway view of the aorta having the transcatheter valve shown in FIG. 20 implanted therein.

  Hereinafter, embodiments of the present invention will be described in more detail with reference to the accompanying drawings.

  While the concepts of the present disclosure may be modified in various modifications and variations, specific exemplary embodiments thereof are shown by way of example in the drawings and are described in detail herein. However, it should be understood that the concepts of the present invention are not intended to be limited to the particular forms disclosed. Rather, the exemplary embodiments are intended to include all modifications, equivalents, and alterations included within the spirit and scope of the invention as defined by the appended claims.

  Throughout this specification, “anterior”, “rear”, “inside”, “outside”, “upper”, “lower”, “distal”, “proximal”, etc. Are used in referring to the orthopedic implants and surgical machines described herein and in reference to the patient's native tissue, but the meaning of these terms is both anatomical and in the orthopedic field. Well understood. In the specification and claims, terms used in connection with these anatomy are used in a sense equivalent to their well-understood meanings unless stated otherwise. For example, the term “proximal” means the direction generally closest to the heart and the term “distal” means the direction generally furthest away from the heart.

  2-16 illustrate an exemplary design of an endovascular prosthesis device or endograft device 10 (hereinafter “device 10”). Device 10 is intended to treat most types of ascending aortic aneurysms and is configured to be able to treat any type of ascending aneurysm with or without lesions in the aortic valve and Valsalva sinus. . As will be described in detail below, the device 10 will allow for future coronary and aortic valve treatments, as well as expansion of the fenestrated / branched graft to the aortic arch. Although described later in more detail with reference to FIGS. 17 to 22, a part of the device 10 may be modified and used as a transcatheter valve. Such catheter valves may be introduced through the femoral artery or through the subclavian artery or apex.

  With reference now to FIGS. 2-7, the device 10 includes a proximal component 12 attached to a distal component 14. As shown in FIG. 2, the distal component 14 may be secured to the proximal component 12 during implantation into the patient's aorta 16. After implantation, the proximal component 12 is located in the patient's ascending aorta 18 and the distal component 14 extends distally into the aortic arch 20 of the patient's aorta 16. As will be described in detail below, the distal piece 14 comprises a pair of “Endo-cabrol conduits” or conduits 22, each conduit 22 sized to receive a catheter or stent 24, It is configured so that blood flows through the coronary artery. Device 10 is configured to treat all ascending aneurysms with or without enlarged ST junctions and aortic valve disease.

  As shown in FIG. 3, the proximal component 12 includes a frame 26 that extends from a proximal end 28 to a distal end 30. The frame 26 is attached to a valve 32 (shown in perspective), which is located at the proximal end 28 of the proximal component 12. In the illustrated example, the valve 32 is configured as a bicuspid valve, but it should be understood that in other embodiments, the valve 32 may be a tricuspid valve or a tetracuspid valve. The valve 32 can be made from treated bovine pericardium, or other suitable proven biological or synthetic material. When the proximal component 12 is implanted into the patient's aorta 16, the valve 32 replaces the aortic valve and selectively passes fluid (ie, blood) from the heart to a passage 36 extending into the proximal component 12.

  The valve 32 is housed within a balloon expandable frame 34 of the frame 26. As shown in FIG. 3, a balloon expandable frame 34 can be exemplified by a balloon expandable stent 38 that extends distally from the proximal end 28 of the proximal component 12 and has a length 40 of about 15 mm. . In other embodiments, the length of the stent 38 may be longer or shorter depending on, for example, the patient's anatomy. The stent 38 is tubular and is constructed in an open-cell structure with nitinol, stainless steel, or other metallic material that meets implant specifications. It should be understood that in other embodiments, the stent 38 may be formed from a polymeric material, for example, as a Z-stent structure. In the illustrated example, the outer surface 42 of the stent 38 is coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 44 that can prevent fluid permeation to the outer surface 42. However, it should be understood that the stent 38 may be coated with standard polyester or other non-porous material.

  As shown in FIG. 3, the stent 38 of the balloon expandable frame 34 has a diameter 46. As described in detail below, the balloon expandable frame 34 is expandable from an unexpanded diameter (not shown) to an expanded diameter 46 during implantation. In the illustrated example, the expansion diameter 46 when the frame 34 is expanded is about 26 mm. In other embodiments, the expanded diameter can be larger or smaller than 26 mm depending on the patient's anatomy and the like. An example of a balloon expandable stent is described by Julio C. Palmaz, “Expandable Intraluminal and Methods for Implanting Expandable and Expandable Endoluminal Grafts. U.S. Pat. No. 5,102,417 entitled "Graft, and Method and Apparatus for Implanting an Expandable Intraluminal Graft" and "Valve Prosthesis for Implantation in the Plant" by Henning Rud Andersen et al. US Pat. No. 6,582,462 (Patent Document 2) entitled “Body and a Catheter for Implanting Such Valve Prosthesis”, the disclosure of which is expressly incorporated herein by reference. Incorporated. As will be described in detail below, in the illustrated example, the diameter 46 is larger than the diameter of the aortic annulus 210 (see FIG. 2), and when the proximal part 12 is implanted and the stent 38 is expanded, An interference fit can be formed with the annulus 210.

  The balloon expandable frame 34 is attached to the self-expandable frame 50. In the illustrated example, frame 34 and frame 50 are stitched together to secure distal end 52 of balloon expandable frame 34 to proximal end 54 of frame 50 to form frame 26 of proximal component 12. It should be understood that in another embodiment, frame 34 and frame 50 may be secured via welding or other fasteners. Frame 34 and frame 50 may also be formed as a single monolithic frame.

  As shown in FIG. 3, the self-expanding frame 50 typically has an hourglass shape and is formed from Nitinol, stainless steel, or other metallic material that meets implant standards. It should be understood that in other embodiments, the frame 50 may be formed of a polymeric material. Frame 50 includes an inwardly tapered proximal portion 60, an outwardly tapered intermediate portion 62, and an elongated distal portion 64. The proximal portion 60 includes a proximal end 54 of the frame 50 and has a distal end 66 that connects to the proximal end 68 of the outwardly tapered intermediate portion 62. Proximal portion 60 tapers inwardly between ends 54 and 66, with a diameter at end 54 of about 26 mm and a diameter at end 66 of about 22 mm. In the illustrated example, the length 70 of the proximal portion 60 is about 10 mm, but it should be understood that in other embodiments, the dimensions of the proximal portion 60 are variable depending on the patient's anatomy and the like. .

  The outwardly tapered intermediate portion 62 in the self-expanding frame 50 has a proximal end 68 and a distal end 72 that connects to the proximal end 74 of the elongated distal portion 64. Intermediate portion 62 tapers outwardly, with a diameter at end 68 of about 22 mm and a diameter at end 72 of about 28 mm. In the illustrated example, the length 76 of the intermediate portion 62 is about 10 mm, but in other embodiments, the dimensions of the intermediate portion 62 are variable depending on, for example, the anatomy of the patient. As will be described in detail below, the proximal portion 60 and the intermediate portion 62 are particularly tapered in the proximal component 12 to allow placement of the stent 24 extending from the distal component 14 to the coronary artery.

  The elongated distal portion 64 in the self-expanding frame 50 extends distally from the proximal end 74 to the distal end 30 of the proximal component 12. In the illustrated example, the length 78 of the distal portion 64 is longer than the combined length of the tapered proximal portion 60 and the intermediate portion 62. In one embodiment, the length 78 of the elongate distal portion 64 is about 25 mm and its diameter 80 is about 28 mm, but is not particularly limited thereto. In other embodiments, the size of the distal portion 64 is variable depending on the patient's anatomy and the like. In an exemplary embodiment, the distal portion 64 may taper between the proximal end 74 and the distal end 30.

  As shown in FIG. 3, the proximal portion 60 of the self-expanding frame 50 has an open cell stent structure, and the intermediate portion 62 and the distal portion 64 have a Z stent structure. It should be understood that in other embodiments, the proximal portion 60, the intermediate portion 62, and the distal portion 64 may be formed as a single structure, including an open cell stent structure or a Z stent structure. The proximal portion 60, the intermediate portion 62, and the distal portion 64 may also be formed as a single monolithic part. The outer surface 82 of the self-expanding frame 50 can be coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 84 to prevent permeation of fluid to the outer surface 82. In this way, the entire outer surface of the proximal component 12 can be covered to prevent fluid from permeating through the surface 82. The coating material 84, which is immediately distal to the balloon expandable frame 34, is provided with a “trap door 86” which is opened in the event of a side valve leak. One or more surgical instruments for embolization can then be passed. The entire outer surface of the proximal component 12 may be coated with a low shrinkage Dacron or other synthetic material. It should also be understood that some or all of the proximal component can be coated with a hydrogel or other sealing material.

  As described above, the device 10 also includes a distal component 14 that is secured to the distal end 30 of the proximal component 12 when the device 10 is implanted in the patient's aorta 16. The Referring now to FIG. 4, the distal component 14 includes a frame 100 that extends from the proximal end 102 to the distal end 104 configured to be secured to the proximal component 12. A passage 106 is defined within the frame 100 and extends from the end 102 to the end 104 of the distal component 14. The passage 106 has a diameter 108 and is sized to receive the distal end 30 of the proximal component 12 when the device 10 is assembled.

  In the illustrated example, the proximal component 12 and the distal component 14 are secured using an interference fit between the frame 100 and the distal end 30 of the proximal component 12. Specifically, the diameter 108 of the passage 106 is smaller than the diameter 80 of the proximal component 12. In the illustrated example, the diameter 108 is about 26 mm. It should be understood that in other embodiments, component 12 and component 14 may be secured using stitching or other securing means.

  As shown in FIG. 4, the distal component 14 includes a proximal frame 110 that couples to an elongated distal frame 112. Proximal frame 110 and distal frame 112 are formed of Nitinol, stainless steel, or other metallic material that meets implant specifications. It should be understood that in other embodiments, the frame 110 and the frame 112 may be formed of a polymeric material. Proximal frame 110 is formed with a Z-stent structure and distal frame 112 is formed with an open cell structure. Frame 110 and frame 112 are each self-expanding. In the illustrated example, the distal frame 112 is secured to the distal end 114 of the proximal frame 110 by stitching the frames 110 and 112 together. It should be understood that in other embodiments, the frame 110 and the frame 112 may be secured via welding or other fasteners. Frame 110 and frame 112 may also be formed as a single monolithic frame.

  Proximal frame 110 has an outer surface 120 coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or other non-porous coating material 122. As a result, permeation of fluid to the surface 120 is prevented. The distal frame 112 is uncovered and is permeable to fluid through an opening 124 formed in the distal frame.

  As shown in FIG. 4, the proximal frame 110 includes a proximal portion 126, an outwardly tapered portion 128 extending from the proximal portion 126 in the distal direction, and an elongated distal portion 130. Proximal portion 126 includes a proximal end 102 of distal piece 14 and has a distal end 132 that connects to proximal end 134 of outwardly tapered portion 128. In the illustrated example, the length 136 of the proximal portion 126 is about 25 mm, but in other embodiments, the dimensions of the proximal portion 126 are, for example. It should be understood that it can be varied according to the patient's anatomy and the like.

  The tapered portion 128 of the frame 110 has a proximal end 134 and a distal end 140 that connects to the proximal end 142 of the elongated distal portion 130. The taper 128 tapers outward from a diameter of about 26 mm at the end 132 to a diameter of about 44 mm to 48 mm at the end 140. In the illustrated example, the length 146 of the tapered portion 128 is about 10 mm, but in other embodiments, it is understood that the dimensions of the tapered portion 128 can vary depending on, for example, the patient's anatomy. I want.

  The elongated distal portion 130 in the frame 110 extends distally from the proximal end 142 to the distal end 114 of the frame 110. In the illustrated example, the distal portion 130 has a length 150. In one example, the length 150 of the elongate distal portion 130 is about 20 mm and the diameter 152 of the distal portion 130 is about 44 mm to 48 mm, but is not limited thereto. In other embodiments, the dimensions of the distal portion 130 are variable depending on the patient's anatomy and the like.

  As described above, the distal component 14 further includes a pair of conduits 22 that couple to the proximal frame 110. Each conduit 22 has a distal end 160 secured to the tapered portion 128 of the frame 110 and a proximal end 162 located adjacent to the proximal end 102 of the proximal component 12. As shown in FIG. 4, the conduit 22 does not extend beyond the proximal end 102 of the proximal component 12. Each conduit 22 has a passage 164 that extends from end 160 to end 162 and is sized to receive the stent 24.

  The passage 164 has a proximal opening 166 defined at the end 162. The diameter 168 of the opening 166 is about 5 mm in the exemplary embodiment. As shown in FIG. 5, the passage 164 has a distal opening 170 defined in the end 160 and the taper 128 of the frame 110. The diameter 172 of the distal opening 170 is larger than the diameter 168. In the illustrated example, the diameter 172 is about 8 mm. The diameter of the passage 164 is about 8 mm over a distance 174 of about 5 mm, but tapers smoothly therefrom, resulting in a diameter 168 at the connection 176 of about 5 mm. The passage 164 maintains a diameter 168 between the connection 176 and the proximal opening 166. In the illustrated example, the length 180 of the passage 164 is about 2 cm between the connection 176 and the proximal opening 166.

  Each conduit 22 is reinforced with a wire, allowing the catheter or stent 24 to pass through, regardless of the orientation, and can be easily intubated into the coronary ostium. As will be described in detail below, this configuration allows the coronary artery 182 (see FIG. 2) to be stented before the proximal component 12 is placed. In the illustrated example, the tapered shape of the tapered portion 128 prevents the stent from being pressed between the ST junction and the device 10 itself, allowing the stent 24 to proceed to the coronary artery 182 without obstruction.

  As shown in FIG. 4, the elongated distal frame 112 at the distal component 14 extends distally from the distal end 114 of the frame 110 to the distal end 104 of the distal component 14. In the illustrated example, the frame 112 has a length 190. In one embodiment, although not particularly limited, the length 190 of the long frame 112 is about 10 cm, which is long enough to cover the arch 20 of the aorta 18 when implanted. In other embodiments, the dimensions of the frame 112 are variable depending on, for example, the patient's anatomy. The distal frame 112 allows the distal component 14 to be accurately placed without compromising blood circulation to the upper branch of the aortic valve. This also allows intubation into the supra-aortic partial branch when a fenestration / branch arch device needs to be placed.

  In implanting the device 10 into the patient's aorta 16, the surgeon can either access the common femoral artery percutaneously or expose the femoral artery. Access to the iliac artery or iliac conduit may be provided. After accessing the site and placing a hard wire in the ascending artery 18, the device 10 and delivery system are prepared. In the illustrated example, the delivery system consists of a hydrophilic sheath body of 100 cm to 105 cm. As shown in FIG. 6, first, the distal part 14 is fed. After performing side oblique thoracic aorta imaging, the distal component 14 is positioned so that the distal end 114 of the proximal frame 110 is located proximal to the innominate artery 200. In this way, the distal opening 170 of the conduit 22 can be positioned with respect to the anonymous artery 200 in the 12 o'clock and 6 o'clock directions.

  A standard coronary guide catheter is introduced into each conduit 22 through the distal frame 112 of the distal component 14 using a contralateral common femoral artery wire. Prior to inserting the stent 24, the catheter is intubated into the conduit 22. As an alternative, a catheter may be previously inserted into the conduit 22. The left and right coronary arteries 182 can be accessed using a catheter. As shown in FIG. 7, the stent 24 is advanced from the distal opening 170 into the passage 164 and out of the conduit 22 to connect the coronary artery 182 and the conduit 22. In this way, each artery 182 connects with a respective conduit 22. Each stent 24 is coated and can be embodied as a balloon expandable stent or a self-expandable stent. It should be understood that the coronary artery bypass may be performed on the left and right coronary arteries prior to placement of the distal component 14.

  The proximal component 12 may be placed after the implant of the distal component 14 is complete. The placement of the proximal component 12 and the distal component 14 may be performed in a single surgical procedure performed in a day, or the distal component 14 may be deployed in a single procedure and another procedure performed at a later date. The proximal part 12 may be arranged by: As shown in FIG. 2, the proximal component 12 is placed in a position across the native aortic valve 202.

  To place the proximal component 12, a hard wire is passed through the aortic valve 202 and into the left ventricle 204. The system that delivers the proximal component 12 passes through the valve 202. “Expandable Intraluminal Graft, and Method and Apparatus for Implanting,” said Julio C. Palmaz, “Extendable Intraluminal Graft, and Method and Apparatus for Implanting. An example of a delivery system is described in US Pat. No. 5,102,417 entitled “An Expandable Intraluminal Graft”, the contents of which are hereby incorporated by reference. . After the delivery system is in place, the system is withdrawn from the sheath body to release the proximal part 12 and thereby expand the self-expanding frame 50. As described above, the self-expanding frame 50 and the proximal end 102 of the distal part 14 are engaged to secure the proximal part 12 and the distal part 14 together, so that the distal part of the proximal part 12 End 30 is sealed within distal component 14. As shown in FIG. 2, the proximal end 28 of the proximal component 12 is located in the aortic annulus, and the proximal component 12 having an hourglass shape creates a space for the leaflets of the native aortic valve. Will not be pressed or overlaid on the opening of the coronary artery 182.

  Balloon expandable frame 34 may be positioned to expand the balloon within the delivery system. As a result, the frame 34 is expanded to a predetermined diameter 46 after being expanded, and is advanced in the blood vessel to engage with the aortic annulus 210 to block the aortic annulus 210. Thus, fluid will only flow from the left ventricle through the valve 32. As shown in FIG. 2, the valve 32 is located in the aortic annulus 210 proximal to the coronary artery 182. It will be appreciated that the placement of the proximal component 12 may be performed during rapid ventricular pacing (RVP). In the case of aortic valve stenosis, the valve 32 may be inflated by angioplasty using a balloon before the proximal component 12 is introduced.

  8-16, another embodiment of the proximal component 212 of the device 10 is shown. Some elements of the embodiment illustrated in FIGS. 8-16 are substantially similar to those described above in connection with the embodiment of FIGS. Each of these elements is shown in FIGS. 8 to 16 with the same reference numerals as those used in FIGS. Similar to the proximal component 12 of FIGS. 1-7, the proximal component 212 can be secured to the distal component 14 when implanted in the patient's aorta 16. After implantation, the proximal component 212 is located in the patient's ascending aorta 18 and the distal component 14 extends distally to the arch 20 of the patient's aorta 16.

  As shown in FIG. 8, the proximal component 212 includes a double frame 214 that extends from the proximal end 28 to the distal end 30. Frame 214 is attached to valve 32 (shown in perspective), with valve 32 located at proximal end 28 of proximal component 212. In the illustrated example, the valve 32 is configured as a bicuspid valve, but it should be understood that in other embodiments, the valve 32 may be a tricuspid valve or a tetracuspid valve. The valve 32 can be made from treated bovine pericardium, or other suitable proven biological or synthetic material. When the proximal component 212 is implanted into the patient's aorta 16, the valve 32 replaces the aortic valve and selectively passes fluid (ie, blood) from the heart to a passage 36 extending into the proximal component 212.

  The double frame 214 of the proximal component 212 includes a self-expanding outer frame 216 and a balloon-expanding inner frame 218 that is secured to the self-expanding outer frame 216 and houses the valve 32. Referring now to FIG. 9, the self-expanding outer frame 216 has a generally hourglass shape and is formed from Nitinol, stainless steel, or other metallic material that meets implant standards. It should be understood that in other embodiments, the outer frame 216 can be formed from a polymeric material. The outer frame 216 includes an elongated proximal portion 220, an inwardly tapered portion 222, an outwardly tapered intermediate portion 62, and an elongated distal portion 64.

  The elongated proximal portion 220 of the outer frame 216 includes a proximal end 28 of the proximal component 212 and has a distal end 224 that connects to the proximal end 226 of the inwardly tapered portion 222. Proximal portion 220 is embodied as a tubular stent. It should be understood that in other embodiments, the proximal portion 220 can be shaped into a prism, cone, or other geometric shape, depending on the patient's anatomy.

  In the illustrated example, the length 228 of the proximal portion 220 is about 15 mm and the diameter 230 is about 32 mm. It should be understood that in other embodiments, the dimensions of the frame 216 are variable depending on the patient's anatomy. As will be described in detail below, in the illustrated example, the diameter 230 is larger than the diameter of the aortic annulus 210 and an interference fit between the proximal portion 220 and the annulus 210 when the proximal component 212 is implanted. Is to be formed. As shown in FIG. 9, the proximal portion 220 defines a passage 232 in the outer frame 216.

  In the illustrated example, collagen fibers 234 are attached to the proximal portion 220 and play an auxiliary role in preventing paravalvular leakage and preventing displacement of the proximal component 212 within the aortic wall. Some fibers 234 extend outward from the proximal portion 220 and some extend inward toward the passageway 232. It will be appreciated that in other embodiments, the outer frame 216 may be covered with a hydrogel or other sealing material. In another embodiment, multiple barbs or hooks may be attached to the proximal portion 220. The hook can be configured to further engage the tissue of the aorta to prevent the device 10 from slipping.

  The inwardly tapered portion 222 of the outer frame 216 has a distal end 236 that includes a proximal end 226 and connects to the proximal end 68 of the outwardly tapered intermediate portion 62. Taper 222 tapers inwardly between ends 226 and 236, with a diameter at end 226 of about 32 mm and a diameter at end 236 of about 22 mm. In the illustrated example, the length 238 of the inwardly tapered portion 222 is about 10 mm.

  The outwardly tapered intermediate portion 62 in the self-expanding frame 216 has a proximal end 68 and a distal end 72 that connects to the proximal end 74 of the elongated distal portion 64. Intermediate portion 62 tapers outwardly from a diameter of about 22 mm at end 68 to a diameter of about 28 mm at end 72. In the illustrated example, the length 76 of the intermediate part 62 is about 10 mm. However, in other embodiments, the dimension of the intermediate part 62 can be varied depending on, for example, the anatomy of the patient.

  The elongate distal portion 64 of the self-expanding frame 216 extends distally from the proximal end 74 to the distal end 30 of the proximal component 212. In the illustrated example, the length 78 of the distal portion 64 is longer than the combined length of the tapered portion 60 and the intermediate portion 62. In one embodiment, the length 78 of the elongate distal portion 64 is about 30 mm and the diameter 80 is about 34 mm, but is not particularly limited thereto. In other embodiments, the dimensions of the distal portion 64 can be variable depending on, for example, the patient's anatomy. In certain exemplary embodiments, the distal portion 64 may taper between the proximal end 74 and the distal end 30.

  As shown in FIG. 9, the proximal portion 220 and the inwardly tapered portion 222 of the self-expanding frame 216 are formed to have an open cell stent structure, and the intermediate portion 62 and the distal portion 64 have a Z stent structure. Formed. It should be understood that in other embodiments, the intermediate portion 62, the distal portion 64, the proximal portion 220, and the tapered portion 222 may be formed as a single structure, including an open cell stent structure or a Z-stent structure. . The intermediate portion 62, the distal portion 64, the proximal portion 220, and the tapered portion 222 may also be formed as a single monolithic part. The outer surface 240 of the intermediate portion 62, the distal portion 64, and the tapered portion 222 is coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 242 to allow fluid to permeate the outer surface 240. Can be prevented. The covering material 242 that is immediately distal to the proximal portion 220 is provided with a “trap door 86” that is opened in the event of a side valve leak. One or more surgical instruments for embolization can then be passed. The outer surface 240 of the intermediate portion 62, the distal portion 64, and the tapered portion 222 may be coated with a low shrinkage Dacron or other synthetic material. It should also be understood that part or all of the frame 216 can be coated with a hydrogel or other sealing material.

  As described above, the outer frame 216 of the double frame 214 is secured to the balloon expandable inner frame 218, which is located within the passage 232. As shown in FIG. 10, the valve 32 is accommodated in the frame 218. The balloon expandable frame 218 can be exemplified by a balloon expandable tubular stent 244 having a length 246 of about 15 mm. In other embodiments, the length of the stent 244 may be longer or shorter depending on, for example, the patient's anatomy. The stent 244 is tubular and is constructed in an open-cell structure with nitinol, stainless steel, or other metallic material that meets implant specifications. It should be appreciated that in other embodiments, the stent 244 may be formed from a polymeric material, for example, as a Z-stent structure. In the illustrated example, the outer surface 248 of the stent 244 is coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 250 that can prevent fluid permeation to the outer surface 248. . However, it should be understood that the stent 244 may be coated with standard polyester, expanded porous PTFE (ePTFE) or other non-porous material.

  As shown in FIG. 10, the stent 244 of the inner frame 218 has a diameter 252. As will be described in detail below, the balloon expandable frame 218 is expandable from an unexpanded diameter (not shown) to an expanded diameter 252 during implantation. In the illustrated example, the expanded diameter 252 when the inner frame 218 is expanded is about 26 mm. In other embodiments, the expanded diameter may be greater than or equal to the diameter 230 of the proximal portion 220 of the outer frame 216. As will be described in detail below, in the illustrated example, the expanded diameter 252 is made larger than the diameter of the aortic annulus 210, and when the proximal part 212 is implanted and the inner frame 218 is expanded, An interference fit is formed between the center portion 220 and the annulus 210.

  Referring now to FIG. 11, the inner frame 218 of the double frame component 214 is fixed to the outer frame 216 via a plurality of seams 260. It should be understood that in other embodiments, the inner frame 218 may be secured to the outer frame 216 by welding or other fasteners. As shown in FIGS. 11-14, the inner frame 218 and the valve component 32 are located in a passage 232 defined in the self-expanding frame 216. When the inner frame 218 is not expanded, the outer surface 248 of the stent 244 is spaced from the fibers 234 attached to the outer frame 216. In the illustrated example, a gap 264 is defined therebetween, and the size of the gap 264 is about 2 mm to about 3 mm.

  As shown in FIG. 14, the balloon expandable inner frame 218 can be expanded in the direction indicated by arrow 266. As described above, the diameter 230 of the proximal portion 220 of the outer frame 216 is larger than the diameter of the aortic annulus 210. Thus, when the proximal component 212 is implanted, the proximal portion 220 contracts to the diameter size of the annulus 210. Because the expanded diameter 252 of the stent 244 is larger than the diameter of the annulus, the outer surface 248 of the stent 244 engages the fiber 234 (ie, the inner surface of the proximal portion 220 of the outer frame 216) via the dressing 250. To do. As such, the gap 264 is closed and the space between the inner frame 218 and the outer frame 216 is sealed by the fibers 234 and the covering material 250.

  In implanting the endograft device 10 with the proximal component 212 into the patient's aorta 16, the surgeon either percutaneously accesses the common femoral artery or exposes and accesses the femoral artery. It is possible to take a way. The surgeon then implants the distal component 14 in the manner described above with reference to FIGS. 1-7 and advances the stent 24 to a location within the artery 182. Proximal component 212 may be placed after implantation of distal component 14. . To do so, a hard wire is passed into the left ventricle 204 through the aortic valve 202. The delivery system for proximal component 212 is then passed through valve 202.

  After the delivery system is in place, the system is withdrawn from the sheath body to release the proximal part 12 and thereby expand the self-expanding frame 216. The self-expanding frame 216 and the proximal end 102 of the distal part 14 are engaged to secure the proximal part 212 and the distal part 14 together, and the distal end 30 of the proximal part 212 is distal. Sealed within the part 14.

  When the frame 216 is withdrawn from the sheath body, the proximal portion 220 expands and engages the aortic annulus 210, forming an interference fit between the frame 216 and the annulus 210, securing the device 10 in place. As shown in FIG. 15, the inner frame 218 in the outer frame 216 is initially in an unexpanded state. The balloon structure can be expanded to place the inner frame 218. As the balloon-expanded inner frame 218 expands, the inner frame 218 engages the outer frame 216, thereby pressing the collagen fiber-coated / hydrogel-coated proximal portion 220 of the outer frame 216 against the aortic annulus 210. As shown in FIG. 16, when the frame 216 and the frame 218 are integrally engaged, the annulus 210 and the paravalvular region can be sealed to prevent paravalvular leakage. Thus, fluid is delivered from the left ventricle 204 only through the valve 32 of the proximal component 212. As shown in FIGS. 15-16, the valve 32 is located in the aortic annulus 210 proximal to the coronary artery 182. It should be understood that the proximal component 212 may be placed during rapid ventricular pacing (RVP). In the case of aortic stenosis, the valve 32 may be inflated by angioplasty using a balloon before introducing the proximal component 212.

  In each of the above embodiments, the self-expanding frame portion of the proximal components 12, 212 can greatly improve the accuracy and control when placing the device 10. Since the valve 32 has a bicuspid valve structure, the following three objects can be achieved. (1) The profile can be lowered by reducing the number of valve commissures to two, (2) the valve 32 can be adapted to the aortic annulus more highly, and (3) the annulus is asymmetric , The incidence of aortic regurgitation can be reduced.

  Here, referring to FIGS. 17 to 22, the proximal part 12 or the proximal part 212 can be used as a transcatheter valve with some modifications. As detailed below, such a valve can be placed in the femoral or axillary pathway.

  An embodiment of a transcatheter valve component 312 is shown in FIGS. Some elements of the embodiment illustrated in FIGS. 17-19 are substantially similar to those described above with respect to the proximal component 12 of FIGS. Each of these elements is shown in FIGS. 17 to 19 using the same reference numerals as those used in FIGS. Similar to the proximal component 12 of FIGS. 1-7, the transcatheter valve component 312 includes a frame 26 that extends from the proximal end 28 to the distal end 30. Frame 326 is attached to valve 32 (shown in perspective), and valve 32 is located at proximal end 28 of valve component 312. When the valve component 312 is implanted in the patient's aorta 16, the valve 32 replaces the aortic valve and selectively allows fluid (blood) to flow from the heart into the passage 36 extending into the valve component 312.

  The valve 32 is housed within a balloon expandable frame 34 of the frame 26. As shown in FIG. 17, the balloon expandable frame 34 can be exemplified by a balloon expandable stent 38 that extends distally from the proximal end 28 of the transcatheter valve component 312 and has a length 40 of about 15 mm. It is. In other embodiments, the stent 38 may be longer or shorter depending on, for example, the patient's anatomy. The stent 38 is tubular and is constructed in an open-cell structure with nitinol, stainless steel, or other metallic material that meets implant specifications. It should be understood that in other embodiments, the stent 38 is formed from a polymeric material, for example, can be formed as a Z-stent structure. In the illustrated example, the outer surface 42 of the stent 38 is coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 44 that can prevent fluid permeation to the outer surface 42. However, it should be understood that the stent 38 may be coated with standard polyester, expanded porous PTFE (ePTFE), or other non-porous material.

  As shown in FIG. 17, the stent 38 of the balloon expandable frame 34 has a diameter 46, which will be described in detail below, but can be expanded from an unexpanded diameter (not shown) to an expanded diameter 46 during implantation. is there. In the illustrated example, when the frame 34 is expanded, its diameter 46 is about 26 mm. In other embodiments, the expanded diameter may be larger or smaller than 26 mm, depending on, for example, the patient's anatomy. In the illustrated example, the diameter 46 is larger than the diameter of the aortic annulus 210, and when the transcatheter valve component 312 is implanted, an interference fit is formed between the stent 38 and the annulus 210.

  Balloon expandable frame 34 is attached to self-expandable frame 350. In the illustrated example, the distal end 52 of the balloon expandable frame 34 is secured to the proximal end 54 of the frame 350 by sewing together the frame 34 and the frame 350 to form the frame 26 of the transcatheter valve component 312. Yes. It should be understood that in other embodiments, frame 34 and frame 350 may be secured via welding or other fasteners. Frame 34 and frame 350 may also be formed as a single monolithic frame.

  As shown in FIG. 17, the self-expanding frame 350 has a generally hourglass shape and is formed from Nitinol, stainless steel, or other metallic material that meets implant standards. It should be understood that in that alternative embodiment, the frame 350 may be formed from a polymeric material. Frame 350 includes an inwardly tapered proximal portion 360, an outwardly tapered intermediate portion 62, and an elongated distal portion 64. The proximal portion 360 includes the proximal end 54 of the frame 350 and has a distal end 66 that connects to the proximal end 68 of the outwardly tapered intermediate portion 62. Proximal portion 360 tapers inwardly between ends 54 and 66, with a diameter at end 54 of about 26 mm and a diameter at end 66 of about 22 mm. In the illustrated example, the length 70 of the proximal portion 360 is about 15 mm.

  The outwardly tapered intermediate portion 62 in the self-expanding frame 350 has a proximal end 68 and a distal end 72 that connects to the proximal end 74 of the elongated distal portion 64. Intermediate portion 62 tapers outwardly from a diameter of about 22 mm at end 68 to a diameter of about 28 mm at end 72. In the illustrated example, the length 76 of the intermediate portion 62 is about 10 mm, but in other embodiments, the dimensions of the intermediate portion 62 may be variable depending on, for example, the anatomy of the patient.

  The elongated distal portion 64 in the self-expanding frame 350 extends distally from the proximal end 74 to the distal end 30 of the valve component 312. In the illustrated example, the length 78 of the distal portion 64 is longer than the combined length of the tapered portions 60 and 62. In one embodiment, the length 78 of the elongate distal portion 64 is about 30 mm and its diameter 80 is about 34 mm, but is not particularly limited thereto. In other embodiments, the dimensions of the distal portion 64 can be variable depending on, for example, the patient's anatomy. In one exemplary embodiment, the distal portion 64 may taper between the proximal end 74 and the distal end 30.

  As shown in FIG. 17, the proximal portion 360 of the self-expanding frame 350 is formed to have an open cell stent structure, and the intermediate portion 62 and distal portion 64 are formed to have a Z stent structure. In other embodiments, the proximal portion 360, the intermediate portion 62, and the distal portion 64 can be formed as a single structure, including an open cell stent structure, a meshed stent structure, or a Z stent structure. I want to be. Proximal portion 360, intermediate portion 62, and distal portion 64 may also be formed as a single monolithic piece.

  As shown in FIG. 17, the outer surface 314 of the proximal portion 360 of the frame 350 is not coated, allowing fluid to pass through the opening 318. The outer surface 316 of the intermediate portion 62 and the distal portion 64 can be coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or non-porous coating material 84 to prevent permeation of fluid to the outer surface 320. The outer surface 320 of the valve component 312 may be coated with a low shrinkage Dacron or other synthetic material. The uncoated open cell stent portion 360 is configured to allow perfusion of the coronary artery. The coverings 62, 64 serve to secure the valve component 312 relative to the aorta 18 and provide a docking station when the ascending aorta is expanded or a fenestration / branch arch graft is performed. In addition, the covering portions 62 and 64 can also perform end graft expansion in the valve component 312 suitable for the B-type aneurysm without expansion of the ST junction.

  Delivery of the transcatheter valve component 312 can begin with access to the left ventricle across the native aortic valve. The position of the left and right coronary arteries may be specified by performing ascending aorta imaging. The valve component 312 is introduced into the aorta 18 using an over the wire introducer system with a guide wire. After the guide wire is placed in the left ventricle 204 via the iliac femoral artery, subclavian artery, or carotid artery, the valve component 312 can be fed through the common femoral artery and passed across the native aortic valve 202. Good. As shown in FIGS. 18-19, after angiography is performed to locate the coronary artery 182, the delivery system is withdrawn from the sheath body to release the valve component 312 and the self-expanding frame 350 expands.

  Here, the balloon expandable frame 34 may be placed after the balloon is inflated in the delivery system. As shown in FIGS. 18 to 19, this causes the frame 34 to be expanded to a predetermined expanded diameter 46, advanced in the blood vessel, and engaged with the aortic annulus 210 to seal the aortic annulus 210. Thus, fluid will flow from the left ventricle only through valve 32 and valve 32 will be located in the aortic annulus 210 proximal to coronary artery 182. Since the uncovered portion 360 of the valve component 312 has the opening 318, blood can flow into the coronary artery 182 and blood circulation is promoted. It should be understood that the placement of the valve component 312 may be performed during rapid ventricular pacing (RVP).

  Next, another embodiment of a transcatheter valve part (hereinafter, valve part 412) is shown in FIGS. Some elements of the embodiment illustrated in FIGS. 20-22 are substantially similar to those described above for the proximal component 212 of FIGS. Each of these elements is shown in FIGS. 20-22 using the same reference numerals as those used in FIGS. Similar to the proximal component 212 of FIGS. 8-16, the valve component 412 includes a double frame 414 extending from the proximal end 28 to the distal end 30. Frame 414 is attached to valve 32 (shown in perspective), and valve 32 is located at proximal end 28 of component 412. In the illustrated example, the valve 32 is configured as a bicuspid valve. Implanting the valve component 412 into the patient's aorta 16 replaces the valve 32 with the aortic valve and selectively allows fluid (blood) to pass through the passage 36 extending from the heart into the valve component 412.

  The double frame 414 includes a self-expanding outer frame 416 and a balloon-expanding inner frame 218 that is fixed to the self-expanding outer frame 416 and accommodates the valve 32. Referring to FIG. 20, the self-expanding outer frame 416 has a generally hourglass shape and is formed from Nitinol, stainless steel, or other metallic material that meets implant standards. It should be understood that in other embodiments, the outer frame 416 may be formed from a polymeric material. The outer frame 416 includes an elongated proximal portion 220, an inwardly tapered portion 422, an outwardly tapered intermediate portion 62, and an elongated distal portion 64.

  The elongated proximal portion 220 of the outer frame 416 includes a proximal end 28 of the component 412 and has a distal end 224 that connects to the proximal end 226 of the inwardly tapered portion 222. Proximal portion 220 is embodied as a tubular stent. It should be understood that in other embodiments, the proximal portion 220 can be shaped into a prism, cone, or other geometric shape, for example, depending on the patient's anatomy.

  In the illustrated example, the length 228 of the proximal portion 220 is about 15 mm and its diameter 230 is about 32 mm. It should be understood that in other embodiments, the dimensions of the frame 416 are variable depending on the patient's anatomy. As will be described in detail below, in the illustrated example, the diameter 230 is made larger than the diameter of the aortic annulus 210, and when the valve component 412 is implanted, the diameter of the proximal portion 220 and the annulus 210 is reduced. An interference fit is formed between them. As shown in FIG. 20, the proximal portion 220 defines a passage 232 in the outer frame 416.

  In the illustrated example, a collagen fiber 234 is attached to the proximal portion 220 and plays an auxiliary role in preventing paravalvular leakage and preventing displacement of the valve component 412 in the aortic wall. Some fibers 234 extend outward from the proximal portion 220 and others extend inward toward the passageway 232. It will also be appreciated that in other embodiments, the outer frame 216 may be covered with a hydrogel or other sealing material. In other embodiments, multiple barbs and hooks may be attached to the proximal portion 220. The hook can be configured to further engage aortic tissue to prevent displacement of the device 10.

  The inwardly tapered portion 422 of the outer frame 416 includes a proximal end 226 and a distal end 236 that connects to the proximal end 68 of the outwardly tapered intermediate portion 62. The tapered portion 422 tapers inwardly between the ends 226 and 236, and the diameter at the end 226 is about 32 mm and the end 236 is about 22 mm. In the illustrated example, the length 238 of the inwardly tapered portion 422 is about 10 mm.

  The outwardly tapered intermediate portion 62 in the self-expanding frame 416 has a proximal end 68 and a distal end 72 that connects to the proximal end 74 of the elongated distal portion 64. Intermediate portion 62 tapers outwardly from a diameter of about 22 mm at end 68 to a diameter of about 28 mm at end 72. In the illustrated example, the length 76 of the intermediate portion 62 is about 10 mm. However, in other embodiments, the dimension of the intermediate portion 62 can be made variable according to, for example, the anatomy of the patient.

  The elongated distal portion 64 of the self-expanding frame 416 extends distally from the proximal end 74 to the distal end 30 of the part 412. In the illustrated example, the distal portion 64 has a length 78, which is longer than the combined length of the tapered portion 60 and the intermediate portion 62. In one embodiment, the length 78 of the elongated distal portion 64 is about 30 mm and the diameter 80 is about 34 mm, but is not particularly limited thereto. In other embodiments, the dimensions of the distal portion 64 can be variable depending on, for example, the patient's anatomy. In certain exemplary embodiments, the distal portion 64 may taper between the proximal end 74 and the distal end 30.

  As shown in FIG. 20, the proximal portion 220 and the inwardly tapered portion 422 of the self-expanding frame 416 are formed to have an open cell stent structure, and the intermediate portion 62 and the distal portion 64 have a Z stent structure. Formed. In other embodiments, the intermediate portion 62, the distal portion 64, the proximal portion 220, the tapered portion 422 may be formed as a single structure, including an open cell stent structure, a mesh stent structure, or a Z stent structure. Please understand that it is good. The intermediate portion 62, the distal portion 64, the proximal portion 220, and the tapered portion 422 may also be formed as a single monolithic part. Each outer surface 440 of the intermediate portion 62 and distal portion 64 is coated with a low shrinkage polyester, expanded porous PTFE (ePTFE), or other non-porous coating material 442 to prevent fluid permeation to the surface 440. it can. The outer surface 444 of the tapered portion 422 does not cover and fluid can permeate through the opening 446 defined by the surface 444. The coverings 62, 64 serve to secure the valve component 312 relative to the aorta 18 and provide a docking station when the ascending aorta is expanded or a fenestration / branch arch graft is performed.

  As described above, the outer frame 416 of the double frame 414 is secured to the balloon expandable inner frame 218, which is located within the passage 232 and houses the valve 32. As described above, the balloon expandable frame 218 is expandable from an unexpanded diameter 450 to an expanded diameter (not shown) during implantation.

  When placing the valve component 412, a hard wire is passed through the aortic valve 202 into the left ventricle 204. The valve 202 is then passed through a delivery system for the valve component 412. After the delivery system is in place, the delivery system is withdrawn from the sheath body to release the valve component 412, thereby expanding the self-expanding frame 416. As the proximal portion 220 of the frame 416 expands and engages the aortic annulus 210, an interference fit is formed between the frame 416 and the annulus 210, allowing the valve component 412 to be secured in place. As shown in FIG. 21, the internal frame 218 in the external frame 416 is initially in an unexpanded state. The inner frame 218 can be placed by expanding the balloon structure. As the balloon expandable inner frame 218 expands, the inner frame 218 engages the outer frame 416 and the collagen fiber-coated / hydrogel-coated proximal portion 220 of the outer frame 416 is pressed against the aortic annulus 210.

  As shown in FIG. 22, when the frame 218 and the frame 416 are integrally engaged, the annulus 210 and the valve side region can be sealed to prevent side valve leakage. Thus, fluid is sent from the left ventricle 204 only through the valve 32 of the part 412. The opening 446 provided in the uncovered portion 422 in the valve component 412 allows blood to flow into the coronary artery 182 and promotes blood circulation.

  The design of the parts 12, 14, 212 and the transcatheter valves 312, 412 also deliberately take into account the case of a dysfunctional condition and is also intended to compensate for such dysfunction. Please understand that. For example, parts 12, 14, 212 can correct paravalvular leakage. More specifically, for paravalvular leakage (Ia type end leak), leakage near the valve 32 acts as an Ia type end leak. Through the trap door 86 of the parts 12, 312, coil embolization of the leakage area is possible. The entire region above the aortic annulus is accessible via two trap doors at 180 degrees. Because the coronary artery 182 is protected by the conduit 22 in the distal component 14, coil embolization in this region does not impair the coronary artery blood flow. Clinically, paravalvular coil embolization has already been performed if there is further leakage near the valve after heart valve surgery.

  Aortic regurgitation (AI) after implantation can also be corrected. After transcatheter valve implantation, significant AI has been confirmed to occur in less than 17% of patients. With the exception of severe calcification of the annulus, the current tricuspid valve configuration and the oval shape of the aortic annulus cause valvular dysfunction that causes AI. The nature of the bicuspid valve of the design discussed herein makes it possible to eliminate joint failure and subsequent AI problems.

  Structural valve alterations can also be corrected. More specifically, by designing a bicuspid valve, it is possible to install another transcatheter valve across the first transcatheter valve without hindering the fluid region of the valve. .

  Coronary failure can also be corrected. The endcablor conduit 22 connected to the tapered portion 128 of the part 14 allows blood to flow through the coronary artery without interruption. Initial placement of the component 14 allows the surgeon to work through the cabrol conduit 22 and to intubate the left and right coronary arteries using standard catheters and guidewires. A stent 24 is placed between the coronary artery and the cabrol conduit 22. The part 12 or the part 212 may be placed after confirming the flow of blood flow to the coronary artery. The tapered design can mitigate the risk that the coronary stent will be clamped between the device 10 and the aortic wall.

  In the case of the transcatheter valves 312 and 412, the paravalve leakage can be corrected. Since the intermediate portions 360 and 422 of the valve have an open cell structure, it is possible to perform coronary artery intubation and stent placement after performing coronary artery protection as necessary, and to perform coil embolization for leakage. .

  Structural valve alterations within the transcatheter valves 312 and 412 can also be corrected. By designing a bicuspid valve, it is possible to install another transcatheter valve across the first transcatheter valve without obstructing the fluid region of the valve.

  The double frame component may take the form of another transcatheter valve replacement device, such as a prosthetic mitral valve or a tricuspid valve. Double frame parts are also used to improve the sealing zone of endovascular devices, and may be used to treat abdominal and thoracic aneurysms and peripheral vascular disease.

  It will be appreciated that the devices and methods described herein are widely applicable. Each of the above-described embodiments has been selected and described for the purpose of describing some of the principles of the method and apparatus and some of its practical applications. The preceding description will allow other persons skilled in the art to use the method and apparatus in various embodiments, with various modifications to the extent that is compatible with the particular possible use. In accordance with the provisions of patent law, the principles and manner of implementation of the present disclosure have been described and illustrated as exemplary embodiments.

  The scope of the method and apparatus of the present invention is intended to be defined by the following claims. However, it should be understood that this disclosure may be practiced otherwise than as specifically described and illustrated without departing from the spirit or scope of the present invention. Those skilled in the art will appreciate that various modifications of the embodiments described herein can be made without departing from the spirit or scope defined by the following claims when implementing the contents described in the claims. It should be understood that examples are available.

  The scope of the present disclosure should be defined not with reference to the above description, but with reference to the appended claims, including equivalents to the full scope of the rights given to the appended claims. It is. Since the technical fields discussed herein foresee and intend for future development, the disclosed systems and methods will be incorporated into such future examples. Moreover, all terms used in the claims are given the broadest valid interpretation and ordinary meaning of those terms as understood by one of ordinary skill in the art unless expressly stated otherwise herein. Intended to be. In particular, when the singular form ("a", "the", "said", etc.) is used, unless stated otherwise, the stated element is within the scope of the claims. Should be interpreted as one or more. It is intended that the following claims define the scope of the disclosure and thus include within the scope and the equivalent methods and apparatus within the scope of the claims. In summary, it is to be understood that this disclosure is capable of modification and variation and is limited only by the following claims.

Claims (19)

An endograft device for endovascular repair of an ascending aortic aneurysm,
A first prosthesis component including a frame extending from a proximal end to a distal end of the first prosthesis component, the first prosthesis component frame comprising: (i) a proximal frame; (ii) the is secured to the proximal frame comprises a distal frame extending to the distal end of the first prosthesis part, and a first prosthesis component,
A second prosthesis component secured to the proximal end of the first prosthesis component, comprising a balloon expandable frame extending distally from the proximal end of the second prosthesis component; Prosthetic parts,
A valve element secured to the balloon expandable frame at a proximal end of the second prosthesis component;
Equipped with a,
The first and second prosthetic components are end grafts that can be secured using an interference fit between the frame of the first prosthetic component and the distal end of the second prosthetic component. device.   The end graft device of claim 1, further comprising a self-expanding frame coupled to the balloon expandable frame, the self-expanding frame having an hourglass shape. The self-expanding frame is
A first portion that tapers inwardly between a proximal end and a distal end;
A second portion having a proximal end coupled to the distal end of the first portion and tapering outwardly between the proximal and distal ends of the second portion; A second part characterized by:
The endograft device according to claim 2, comprising:   The end graft device of claim 3, wherein a proximal end of the first portion is secured to a distal end of the balloon expandable frame. The self-expanding frame comprises a third portion extending proximally from a proximal end of the first portion, the third portion having a passage defined therein;
4. The endograft device of claim 3, wherein the balloon expandable frame is located within the passage of the third portion of the self-expanding frame.   The balloon expandable frame includes: (i) an unexpanded position where an outer surface of the balloon expandable frame is separated from an inner surface of the self-expandable frame; and (ii) an outer surface of the balloon expandable frame is 6. The endograft device of claim 5, wherein the endograft device is expandable between an expanded position that engages an inner surface of the self-expanding frame.   A plurality of fibers are attached to the third portion of the self-expandable frame, and the outer surface of the balloon expandable frame engages the plurality of fibers when the balloon expandable frame is in the expanded position. The endograft device according to claim 6.   The proximal frame of the first prosthesis component has a passage defined therein, and a distal end of the second prosthesis component is located within the passage of the first prosthesis component. 2. The endograft device according to 1.   The apparatus further comprises at least one conduit secured to the first prosthesis component and positioned adjacent to the proximal frame, the at least one conduit being a pair of sides positioned on opposite sides of the first prosthesis component. The endograft device of claim 1, comprising a conduit.   The end graft device of claim 9, wherein the at least one conduit has a proximal opening located adjacent to a proximal end of the first prosthesis component. The proximal frame includes (i) a first portion secured to a distal end of the second prosthetic component, and (ii) a second portion coupled to the first portion, the distal end And a second portion that tapers outwardly between a proximal end coupled to the first portion, and
The end graft device of claim 10, wherein the at least one conduit has a distal opening defined in the second portion of the proximal frame.   12. The endograft device of claim 11, further comprising a stent having a distal end located within a proximal opening of the at least one conduit and a proximal end configured to be located within a coronary artery. Coating the outer surface of the second prosthetic component and the outer surface of the proximal frame of the first prosthetic component to prevent fluid permeation to each surface;
The endograft device of claim 1, wherein fluid permeation to the surface of the first prosthetic component is permitted without coating the outer surface of the distal frame. Frame parts,
A balloon expandable frame extending distally from a proximal end of the frame component;
A first portion secured to the balloon expandable frame and tapered inwardly between a proximal end and a distal end; (ii) a distal end; and a distal end of the first portion A self-expanding frame including a second portion that tapers outwardly between a proximal end secured to
Having frame parts;
A valve element located within the balloon expandable frame at a proximal end of the frame component;
Equipped with a,
The distal end of the self-expanding frame is configured to be fixable using a first prosthesis component including the frame and an interference fit ;
Transcatheter valve. The frame part is a double frame part;
The self-expanding frame is an outer frame of the double frame part and has a passage defined therein;
The balloon expandable frame is an internal frame of the double frame part and is located in the passage defined in the self-expanding frame;
The balloon expandable frame includes: (i) an unexpanded position where an outer surface of the balloon expandable frame is separated from an inner surface of the self-expandable frame; and (ii) an outer surface of the balloon expandable frame is 15. The transcatheter valve of claim 14, wherein the transcatheter valve is expandable between expanded positions that engage an inner surface of the self-expanding frame.   16. The self-expanding frame has a plurality of fibers attached thereto, and an outer surface of the balloon expandable frame engages the plurality of fibers when the balloon expandable frame is in the expanded position. Transcatheter valve.   Enabling the permeation of fluid to the surface without coating the outer surface of the first part of the self-expanding frame and covering the outer surface of the second part of the self-expanding frame; The transcatheter valve according to claim 14, which prevents permeation of fluid into the tube.   The self-expanding frame includes an elongated portion extending in a distal direction from the second portion, and the length of the elongated portion is a combined length of the first portion and the second portion. 15. A transcatheter valve according to claim 14 which is longer than the length. An endograft device for endovascular repair of an ascending aortic aneurysm,
A first prosthetic component comprising a stent frame;
A second prosthesis component comprising an expandable frame secured to a proximal end of the first prosthesis component and extending distally from the proximal end of the second prosthesis component; Prosthetic parts,
A valve element fixed to the second prosthesis component,
A selected one of the first prosthetic component and the second prosthetic component is disposed to engage a first portion of a patient's aorta, and the other selected prosthetic component is the first prosthetic component. in the second part of the aorta of the patient from partial spaced, fixed to the selected prosthetic components, defining the total length of which is a combination of the first prosthesis component and the second prosthetic component And
The first prosthesis component and the second prosthesis component can be secured using an interference fit between the stent frame of the first prosthesis component and the distal end of the second prosthesis component. Graft device.

Images